Literature DB >> 7510471

Inhibition of human immunodeficiency virus type 1 replication by human interferons alpha, beta and gamma.

J K Yamamoto1, M L Kruzel, H Louie, J A Georgiades.   

Abstract

The effect of various preparations of human interferon (HuIFN) upon human immunodeficiency virus (HIV-1) replication in cell lines and primary cultures of peripheral blood lymphocytes (PBL) was investigated. Natural interferon alpha (nHuIFN-alpha) exhibited a much higher inhibitory effect upon HIV-1 replication than did recombinant HuIFN-alpha (rHuIFN-alpha).

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7510471

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN： 0004-069X            Impact factor:   4.291


  6 in total

1.  Allo-antigen stimulated CD8+ T-cells suppress NF-κB and Ets-1 DNA binding activity, and inhibit phosphorylated NF-κB p65 nuclear localization in CD4+ T-cells.

Authors:  Ryuichi Nagashima; Fumitaka Kawakami; Shinichiro Takahashi; Fumiya Obata; Makoto Kubo
Journal:  Viral Immunol       Date:  2014-05-20       Impact factor: 2.257

2.  Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation.

Authors:  L A Pinto; V Blazevic; B K Patterson; C Mac Trubey; M J Dolan; G M Shearer
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Evidence for a different susceptibility of primate lentiviruses to type I interferons.

Authors:  Stéphanie Cordeil; Xuan-Nhi Nguyen; Gregory Berger; Stéphanie Durand; Michelle Ainouze; Andrea Cimarelli
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

4.  Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation.

Authors:  Lawrence Fong; Manuela Mengozzi; Nancy W Abbey; Brian G Herndier; Edgar G Engleman
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 5.  Immunotherapy for prostate cancer.

Authors:  Lawrence Fong; Eric J Small
Journal:  Curr Oncol Rep       Date:  2007-05       Impact factor: 5.945

Review 6.  Immunotherapy for prostate cancer.

Authors:  Lawrence Fong; Eric J Small
Journal:  Curr Urol Rep       Date:  2006-05       Impact factor: 2.862
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.